Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1^-/-mice

• Main Authors: Baumruker Thomas, Urtz Nicole, Niwa Satoru, Billich Andreas, Bornancin Frédéric
• Format: Article
• Language: English
• Published: BMC 2010-01-01
• Series: Lipids in Health and Disease
• Online Access: http://www.lipidworld.com/content/9/1/1

<p>Abstract</p> <p>Ceramide kinase (CERK) produces the bioactive lipid ceramide-1-phosphate (C1P) and is a key regulator of ceramide and dihydroceramide levels. It is likely that CERK and C1P play a role in inflammatory processes but the cells involved and the mechanisms used remain to be clarified. In particular, the impact of CERK on T-cell biology has not been studied so far. Here, we used <it>Cerk</it>^-/-mice backcrossed with DO11.10/RAG1^-/-mice to probe the effect of CERK ablation on T-cell activation. Levels of interleukin (IL)-2, IL-4, IL-5, IL-13, of tumor necrosis factor (TNF)-α, and of interferon (INF)-γ were recorded following ovalbumin challenge in vivo and using ovalbumin-treated splenocytes ex- vivo. Absence of CERK led to a significant decrease in the production of IL-4, thus suggesting that CERK may polarize T cells towards the T_H2 cell subtype. However, the importance of CERK to T_H2 cell biology will have to be investigated further because in a model of asthma, which is T_H2-cell driven, <it>Cerk</it>^-/-mice responded like wild-type animals.</p>